Press Releases
-
Jumo Health Celebrates Ranking on the 2022 Inc. 5000 List of Fastest Growing Companies
Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it is among the fastest growing private companies as reported by Inc. Magazine in its prestigious Inc. 5000 list.
Aug 15, 2022
-
Anju Introduces eTMF Master for Electronic Trial Master File Management in Clinical Studies
-
Saama Appoints Andrew J. (A.J.) Mills as Company’s Chief Commercial Officer
Saama announces appointment of life science industry sales and marketing expert A.J. Mills as company's Chief Commercial Officer.
Aug 14, 2022
-
Saama Collaborates with Merck to Build Machine Learning-Powered Clinical Data Layer to Strengthen Merck’s Clinical Development Capabilities
Saama announces multi-year agreement with Merck to leverage Saama's Life Science Analytics Cloud (LSAC) to build new clinical data layer to strengthen Merck’s clinical development capabilities and expedite pipeline progress.
Aug 9, 2022
-
GLOBAL CLINICAL TRIALS CONNECT 2022
“COLLABORATION, INNOVATION AND ENHANCING QUALITY IN CLINICAL TRIALS” Virtual Conference and Expo
Sep 20, 2022
-
U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia
Alliance Pharma today announced they will be opening a bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.
Aug 10, 2022
-
Research from Beacon Biosignals Presented at Alzheimer's Association International Conference
The researchers concluded that automated analysis of EEG data is a promising way to stratify patients and track disease progression, while enabling better patient selection for clinical trials.
Aug 8, 2022
-
ChargePoint Technology bolsters growth strategy with key appointment
-
150 Orphan Drug Indication Approvals Trusted to Calyx IRT
Trial sponsors rely on Calyx IRT to ensure patient supply during rare disease treatment development
Aug 8, 2022
-
Signant Partners with Loftware for Adaptive Investigational Product Labeling
Signant Health, the leader in evidence generation for modern clinical trials, announced a partnership with Loftware to offer customers integrated clinical trial supply labeling and packaging capabilities. Loftware is the leading provider of labeling and regulated content solutions and can now be integrated with Signant’s SmartSignals™ Supplies solutions to provide customers with a seamless product label design, approval, and production process.
Aug 7, 2022
-
BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes
Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.
Aug 7, 2022
-
Service Portfolio Expanded for Drug Delivery Research
-
Stable and Quality Supply of Phosphoramidites Is a Reality at BOC Sciences
As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products.
Aug 3, 2022
-
Thiophenes as Heterocyclic Organic Compounds for Academic Research and Industrial Manufacturing
-
Peptides for Diabetes Research—a Special Offer of BOC Sciences
BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.
Aug 3, 2022
-
BOC Sciences Shares Its Strategic Emphasis on NTPs during the Pandemic
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.
Aug 3, 2022
-
Donepezil for Alzheimer's Disease Research
-
Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience
Dr. Vince Clinical Research (DVCR) today announced the addition of two key leadership roles to its Phase I research team.
Jul 31, 2022
-
H1 and Lokavant Partner on Data and Analytics to Power Next Generation Clinical Trials
H1, the connecting force for global HCP, clinical, scientific, and research information, and Lokavant, the leading clinical trial intelligence company, today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development. As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.
Aug 2, 2022
-
BrainCheck Launches Investigator Initiated Research (IIR) Grant Program For Brain and Cognitive Disorders Research The BrainCheck IIR Grant is looking to fund research that aids in the early detection and treatment of patient pools experiencing cognit
BrainCheck announced an Investigator Initiated Research (IIR) Grant Program to help fund research for evaluation, diagnosis, treatment and care for brain related disease. This includes, but is not limited to, Alzheimer's disease and related dementias (ADRD), post-operative delirium, stroke, traumatic brain injury, and post-acute Covid “brain fog”. Awardees will be provided one-year research funding and free access to the BrainCheck platform.
Jul 31, 2022